期刊文献+

肝内胆管细胞癌手术治疗策略的进展 被引量:13

Progress on strategy of surgical treatment for intrahepatic cholangiocarcinoma
原文传递
导出
摘要 肝内胆管细胞癌是第2常见的原发性肝癌,易转移复发,预后较差。根治性手术是唯一可能治愈肝内胆管细胞癌的治疗方式。近年来,随着对肝内胆管细胞癌生物学行为认识的深入以及手术技术方法的进步,其手术治疗策略已发生明显的变化,研究者对治疗的手术指征、肝切除范围以及淋巴结清扫等方面也有了新的认识。此外,复发性肝内胆管细胞癌的治疗策略也发生了新的变化。 Intrahepatic cholangiocarcinoma is the second commonest primary malignant tumor in liver. It carries a poor prognosis because of the highly invasive and metastatic charac- ters. Radical resection may be the only cured way for intrahepa- tic cholangiocarcinoma. In the past few years, the surgical strategy has changed a lot due to the understanding of the biological behavior and advance of surgical techniques. These changes mainly focused on the surgical indication, liver resection and lymphadenectomy. In addition, the treatment strategy to the reccurent intrahepatic cholangiocarcinoma has also been evolved.
出处 《中华消化外科杂志》 CAS CSCD 北大核心 2016年第11期1131-1134,共4页 Chinese Journal of Digestive Surgery
基金 国家自然科学基金青年项目(81502433)
关键词 胆管肿瘤 肝内胆管癌 外科手术 治疗 Biliary tract neoplasms Intrahepatic cholangiocarcinoma Surgical procedures, operative Therapy
  • 相关文献

参考文献36

  • 1Aljiffry M, Abdulelah A, Walsh M, et al. Evidence-based ap?proach to cholangiocarcinoma: a systematic review of the current literature[J].J Am Coli Surg,2009,208(I) :134-147. 001:10. 10 16/J.Jamcollsurg. 2008. 09. 007.
  • 2Hersz nyi L, Tulassay Z. Epidemiology of gastrointestinal and liver tumors[J]. Eur Rev Med Pharmacol Sci,2010,14(4) :249-258.
  • 3Khan SA, Toledano MB, Taylor-Robinson SO. Epidemiology, risk factors, and pathogenesis of cholangiocarcinoma[J] . HPB (Oxford) ,2008, 10 (2) : 77 -82. DOl: 10. 1080/136518208019 92641.
  • 4BridgewaterJ, Galle PR, Khan SA, et al. Guidelines for the diag?nosis and management of intrahepatic cholangiocarcinoma[J].J Hepatol,2014 ,60 (6) : 1268-1289. 001: 10. 1016/j.Jhep. 2014. 01. 021.
  • 5夏璇,何晓红,黄清春.误诊为肝内胆管细胞癌的IgG4相关疾病1例[J].第三军医大学学报,2014,36(11):1198-1198. 被引量:1
  • 6onas S, Thelen A, Benckert C, et al. Extended liver resection for intrahepatic cholangiocarcinoma: A comparison of the prognostic accuracy of the fifth and sixth editions of the TNM classification[J]. Ann Surg, 2009,249 (2) : 303-309. 001: 10. 1097/SLA. ObOI3e318195el64.
  • 7Ribero 0, Pinna AD, Guglielmi A, et al. Surgical Approach for Long-term Survival of Patients With Intrahepatic Cholangiocarcino?rna: A Multi-institutional Analysis of 434 Patients[J]. Arch Surg, 2012,147 ( 12): 1107-1113. DOl: 10. 100l/archsurg. 2012. 1962.
  • 8梁廷波,白雪莉.肝门部胆管癌多学科团队的诊断与治疗[J].中华消化外科杂志,2015,14(4):268-274. 被引量:32
  • 9唐啸.根治性切除术辅助肝动脉化疗栓塞治疗肝内胆管细胞癌的疗效和预后分析[J].临床肝胆病杂志,2015,31(2):236-239. 被引量:12
  • 10Liver Cancer Study Group ofJapan. The general rules for the clini?cal and pathological study of primary liver cancer[M]. 2nd English edition. Tokyo: Kanehara ,2003.

二级参考文献82

  • 1Umehara H, Okazaki K, Masaki Y, et al. A novel clinical entity, IgG4-related disease ( IgG4RD ) : general concept and details [ J ]. Mod Rheumatol, 2011, 22( 1 ) : 1 - 14.
  • 2Deshpande V, Zen , Chart J K, et al. Consensus statement on the pathology of IgG4-related disease [ J ]. Mod Pathol, 2012, 25 ( 9 ) : 1181 - 1192.
  • 3Masaki Y, Dong L, Kurose N, et al. Proposal for a new clinical enti- ty, IgG4-positive muhiorgan lymphoproliferative syndrome: analysis of 64 cases of IgG4-related disorders [ J ]. Ann Rheum Dis, 2009, 68 (8) : 1310-1315.
  • 4Dahlgren M, Khosroshahi A, Nielsen G P, et al. Riedel thyroiditis and muhifocal fibrosclerosis are part of the IgG4-related systemic disea- ses spectrum[ J]. Arthritis Care Res ( Hoboken), 2010, 62 (9) : 1312 -1318.
  • 5Kitagawa S, Zen Y, Harada K, et al. Abundant IgG4-positive plasma cell infiltration characterizes chronic selerosing sialadenitis ( Kuttner' s tumor) [J]. Am J Surg Pathol, 2005, 29(6) : 783 -791.
  • 6Umehara H, Okasaki K, Masaki Y, et al. Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011 [J]. Mod Rheuma- to1, 2012, 22(1) : 21 -30.
  • 7Ruys AT, van Beem BE, Engelbrecht MR, et al. Radiological staging in patients with hilar cholangiocarcinoma: a systematic re- view and meta-analysis[ J]. Br J Radiol,2012,85 (1017) :1255- 1262.
  • 8Park HS, Lee JM, Choi JY, et al. Preoperative evaluation of bile duct cancer: MRI combined with MR cholangiopancreatography versus MDCT with direct chulangiography[J]. A JR Am J Roentgenol, 2008,190 ( 2 ) :396-405.
  • 9Li J, Kuehl H, Grabellus F, et al. Preoperative assessment of hi- lar cholangiocarcinoma by dual-modality PET/CT [J]. J Surg Oncol,2008,98 (6) :438-443.
  • 10Bismuth H, Nakache R, Diamond T. Management strategies in re- section for hilar cholangiocarcinoma [J]. Ann Surg, 1992,215 (1) :31-38.

共引文献126

同被引文献101

引证文献13

二级引证文献112

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部